| Literature DB >> 15306094 |
Kaeng W Lee1, Ali Hamaad, Robert J MacFadyen, Gregory Y H Lip.
Abstract
Sudden death is one of the most common modes of death in those who survive a myocardial infarction. A recent study of 11,324 patients showed a marked decrease in risk of sudden cardiac death as well as a reduction in all-cause mortality in the post-myocardial infarction group taking a highly purified form of omega-3 fatty acids, added to the use of other secondary prevention drugs, including b-blockers and lipid-lowering therapy. There is now amounting evidence indicating that the clinical benefits of highly purified omega-3 fatty acids may be attributed to their anti-arrhythmogenic properties. Evidence for this mechanism of benefit is reviewed here.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15306094 DOI: 10.1007/s11886-004-0040-9
Source DB: PubMed Journal: Curr Cardiol Rep ISSN: 1523-3782 Impact factor: 2.931